西二胺的营销后安全监测:利用FAERS数据库进行的药监测研究
Ying Zhang1, Shengzhu Sun1, Yunhong Ning1
1First College of Clinical Medicine, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
Frontiers in psychiatry
|March 11, 2025
概括
这项研究分析了FDA的数据,以确定与治疗严重抑郁症的药物沃尔提胺酸相关的不良事件. 通过突出潜在的副作用,研究结果有助于优化西的使用,并提高患者的安全.
科学领域:
- 药物监督 药物监督 药物监督
- 临床药理学 临床药理学
- 数据挖掘 数据挖掘
背景情况:
- 沃尔提奥塞丁酸是主要治疗主要抑郁症 (MDD) 的关键治疗方法.
- 它的抗抑郁作用包括抑制血清素 (5-HT) 再吸收.
- 了解其不良事件 (AEs) 对患者安全至关重要.
研究的目的:
- 为了调查与氧胺酸相关的副作用.
- 为了提高沃尔提奥谢的临床安全性.
- 为了利用FDA不良事件报告系统 (FAERS) 的数据挖掘.
主要方法:
- 利用了FAERS数据从2013年第三季度到2024年第一季度.
- 使用不成比例分析和报告的比率比率 (ROR) 来识别风险信号.
- 从MedDRA v26.1.1.中分析的系统器官类别 (SOC) 和首选术语 (PT).
主要成果:
- 报告了11,298例怀疑的沃尔提奥克塞丁化的主要病例.
- 经验证书涵盖了27个不同的系统器官类 (SOC).
- 150个首选条款 (PTs) 在四个算法中显示出显著的不成比例.
结论:
- 确定了与沃尔提奥克塞丁化相关的特定不良事件.
- 调查结果为优化西处方提供了洞察力.
- 结果作为安全和合理的临床应用vortioxetine的参考.
相关概念视频
Pharmacovigilance
764
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
764
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Antidepressant Drugs: MAOIs and Other Agents
175
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
175
Clinical Trials: Overview
2.6K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.6K
Antiepileptic Drugs: Potassium Channel Activators
140
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
140
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
67
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
67


